Cargando...

Defining specificity and on-target activity of BH3-mimetics using engineered B-ALL cell lines

One of the hallmarks of cancer is a resistance to the induction of programmed cell death that is mediated by selection of cells with elevated expression of anti-apoptotic members of the BCL-2 family. To counter this resistance, new therapeutic agents known as BH3-mimetic small molecules are in devel...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Oncotarget
Main Authors: Koss, Brian, Ryan, Jeremy, Budhraja, Amit, Szarama, Katherine, Yang, Xue, Bathina, Madhavi, Cardone, Michael H., Nikolovska-Coleska, Zaneta, Letai, Anthony, Opferman, Joseph T.
Formato: Artigo
Idioma:Inglês
Publicado: Impact Journals LLC 2016
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4905489/
https://ncbi.nlm.nih.gov/pubmed/26862853
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.7204
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!